| Study Name | Principal Investigator |
|---|---|
| HZNP-HZN-1116-201: A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome | Schiopu, Elena |
RESEARCH. INNOVATION. DISCOVERY.